...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: RVX-297 -- Twice as selective for BD2 as is apabetalone

Couldn't agree more Golf, after 20 years at this it is sad and shameful that this management group has not been able to take real scientific achievement and translate that into at least one therapeutic to benefit patients. It would appear that this science has provided numerous paths to this end but the business is so poorly run that these paths are unable to be explored. 

Share
New Message
Please login to post a reply